Skip to content
value.today

Elucid Bioimaging Inc.

Total raised
$135 M
2 rounds on record
Latest round
$56 M
Oct 2025
First round on record
Oct 2023
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Elucid Bioimaging Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2025$56 MNo. 2$50 to $250 million

Elucid Bioimaging Inc.: Raise no. 2, Oct 2025

Investors in this round

20 investors had bought by the notice of Oct 27, 2026: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$56 M of $80 M offered; $24 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Blake Richards · Executive Officer
  • Kelly Huang · Executive Officer, Director
  • Evan Melrose · Director
  • Michael Lesh · Director
  • Rajesh Panda · Director
  • Richard Kuntz · Director
  • Scott Huennekens · Director
  • Shamiram Feinglass · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kelly Huang, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Oct 27, 2026. Read the notice at the SEC.

equitySEC
Oct 2023$79 MNo. 1$50 to $250 million

Elucid Bioimaging Inc.: Raise no. 1, Oct 2023

Investors in this round

13 investors had bought by the notice of Nov 22, 2023: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$79 M of $79 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Blake Richards · Executive Officer, Director
  • Scott Huennekens · Executive Officer, Director
  • Evan Melrose · Director
  • Michael Lesh · Director
  • Robert Braun · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Blake Richards, Ceo. Source: SEC Form D, newest notice filed Nov 22, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Elucid Bioimaging Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2026).

    SEC Form D · Oct 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2026

That is all the official record says: Elucid Bioimaging Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Elucid Bioimaging Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 20 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Elucid Bioimaging Inc.
NameRoleNamed in
Blake RichardsExecutive officerOct 2025
Kelly HuangExecutive officerOct 2025
Scott HuennekensExecutive officerNov 2023
Evan MelroseDirectorOct 2025
Kelly HuangDirectorOct 2025
Michael LeshDirectorOct 2025
Rajesh PandaDirectorOct 2025
Richard KuntzDirectorOct 2025
Scott HuennekensDirectorOct 2025
Shamiram FeinglassDirectorOct 2025
Blake RichardsDirectorNov 2023
Robert BraunDirectorNov 2023